Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hsing

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Cell Science|June 21, 2015
Mitf is a master regulator of the v-ATPase, forming a control module for cellular homeostasis with v-ATPase and TORC1Tianyi Zhang, Qingxiang Zhou, Margret Helga Ogmundsdottir, et al.
The Journal of Biological Chemistry|August 3, 2014
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancerKush Dalal, Mani Roshan-Moniri, Aishwariya Sharma, et al.
The Journal of Biological Chemistry|October 27, 2015
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancerKush Dalal, Mani Roshan-Moniri, Aishwariya Sharma, et al.
The Journal of Biological Chemistry|March 12, 2017
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancerKush Dalal, Mani Roshan-Moniri, Aishwariya Sharma, et al.
Human Mutation|January 31, 2014
Prioritizing disease-linked variants, genes, and pathways with an interactive whole-genome analysis pipelineIn-Hee Lee, Kyungjoon Lee, Michael Hsing, et al.
Scientific Reports|March 26, 2024
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancerKevin J Tam, Liangliang Liu, Michael Hsing, et al.
Oncotarget|December 31, 2016
Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent mannerKevin J Tam, Kush Dalal, Michael Hsing, et al.
Circulation Research|December 14, 2011
Polycomb repressive complex 2 regulates normal development of the mouse heartAibin He, Qing Ma, Jingjing Cao, et al.
Chemistry & Biology|December 3, 2014
Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancerRavi S N Munuganti, Mohamed D H Hassona, Eric Leblanc, et al.
Oncotarget|May 4, 2017
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancerMiriam S Butler, Mani Roshan-Moniri, Michael Hsing, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Cell Science|June 21, 2015
Mitf is a master regulator of the v-ATPase, forming a control module for cellular homeostasis with v-ATPase and TORC1Tianyi Zhang, Qingxiang Zhou, Margret Helga Ogmundsdottir, et al.
The Journal of Biological Chemistry|August 3, 2014
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancerKush Dalal, Mani Roshan-Moniri, Aishwariya Sharma, et al.
The Journal of Biological Chemistry|October 27, 2015
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancerKush Dalal, Mani Roshan-Moniri, Aishwariya Sharma, et al.
The Journal of Biological Chemistry|March 12, 2017
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancerKush Dalal, Mani Roshan-Moniri, Aishwariya Sharma, et al.
Human Mutation|January 31, 2014
Prioritizing disease-linked variants, genes, and pathways with an interactive whole-genome analysis pipelineIn-Hee Lee, Kyungjoon Lee, Michael Hsing, et al.
Scientific Reports|March 26, 2024
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancerKevin J Tam, Liangliang Liu, Michael Hsing, et al.
Oncotarget|December 31, 2016
Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent mannerKevin J Tam, Kush Dalal, Michael Hsing, et al.
Circulation Research|December 14, 2011
Polycomb repressive complex 2 regulates normal development of the mouse heartAibin He, Qing Ma, Jingjing Cao, et al.
Chemistry & Biology|December 3, 2014
Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancerRavi S N Munuganti, Mohamed D H Hassona, Eric Leblanc, et al.
Oncotarget|May 4, 2017
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancerMiriam S Butler, Mani Roshan-Moniri, Michael Hsing, et al.
Pageof 4